| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |